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Using Patents to Protect Traditional Knowledge
Abstract

The role that intellectual property can play in the protection of traditional knowledge (TK) has been on the
international agenda for more than ten years, with little to show for it. For example, the World Intellectual
Property Organization (WIPO) has provided a forum for international policy debate on the subject since
1998, and the WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources,
Traditional Knowledge and Folklore (IGC) has held meetings on draft provisions for the protection of TK
against misappropriation and misuse since 2001. Similarly, since 1999 the World Trade Organization (WTO)
has been examining the most effective means to deal with the commercial use of TK when that knowledge is
the subject of patent applications. Years of effort have produced few tangible results. While there has been
little movement internationally, several nations, particularly developing ones, have attempted to provide a
measure of protection for TK at the national or regional level. As international discussions drag on, pressure
will likely increase for countries rich in TK to seek recourse in national or regional solutions. Prominent
among those solutions will be the use of patent law. This article will review the benefits, shortcomings, and
challenges of using patents to protect TK and survey some of the efforts that have been undertaken so far.
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USING PATENTS TO PROTECT
TRADITIONAL KNOWLEDGE
Jay Erstling'
INTRODUCTION

The role that intellectual property can play in the protection of
traditional knowledge2 (TK) has been on the international agenda for
more than ten years, with little to show for it. For example, the World
Intellectual Property Organization (WIPO) has provided a forum for
international policy debate on the subject since 1998, and the WIPO
Intergovernmental Committee on Intellectual Property and Genetic
Resources, Traditional Knowledge and Folklore (IGC) has held meetings on draft provisions for the protection of TK against misappropriation and misuse since 2001.1 Similarly, since 1999 the World Trade
Organization (WTO) has been examining the most effective means to
deal with the commercial use of TK when that knowledge is the subject of patent applications.' Years of effort have produced few tangible results.
While there has been little movement internationally, several nations, particularly developing ones, have attempted to provide a measure of protection for TK at the national or regional level.' As
international discussions drag on, pressure will likely increase for
countries rich in TK to seek-recourse in national or regional solutions.
Prominent among those solutions will be the use of patent law. This
article will review the benefits, shortcomings, and challenges of using
1. Professor of Law, William Mitchell College of Law, St. Paul, Minnesota. From
2002 to 2007, the author was the Director of the Office of the PCT at the World
Intellectual Property Organization (WIPO). Any views expressed in this paper about
either the PCT or WIPO are the author's own. The author would like to thank Brynn
Bauer, a student at William Mitchell, for her contributions to the research that led to
this article.
2. Because so much of a country's traditional knowledge focuses on the use and
management of the country's genetic resources, discussions concerning the intellectual property protection of traditional knowledge are often linked to the protection of
genetic resources. For the purpose of simplicity, this paper attempts to limit itself to
traditional knowledge protection. It should nevertheless be understood that much of
what is said about traditional knowledge applies also to the protection of genetic
resources.
3. See WIPO, Traditional Knowledge, Genetic Resources, and Traditional Cultural Expressions/Folklore, Overview, http://www.wipo.int/tk/en/ (last visited Apr. 1,
2009).
4. See World Trade Organization [WTO], TRIPS: Reviews, Article 27.3(B) and
Related Issues, Background and the Current Situation (2008), http://www.wto.org/
english/tratop-e/trips-e/art27 3b backgrounde.htm.
5. For a compilation of legislative texts that encompass TK protection, see
WIPO, Legislative Texts on the Protection of Traditional Knowledge, http://www.
wipo.int/tk/enllaws/tk.html (last visited Feb. 8, 2009).
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patents to protect TK6 and survey some of the efforts that have been
undertaken so far.
WHAT

Is TRADITIONAL KNOWLEDGE?

There is no one standard definition of TK. The Convention on Biological Diversity,7 an important international agreement that will be
discussed below, reflects the diverse nature of TK when it refers to it
as ". . . knowledge, innovations and practices of indigenous and local
communities embodying traditional lifestyles .. "8 The WIPO IGC
has suggested that TK could be characterized as referring:
...to the content or substance of knowledge that is the result of
intellectual activity and insight in a traditional context, and includes
the know-how, skills, innovations, practices and learning that form
part of traditional knowledge systems, and knowledge that is embodied in the traditional lifestyle of a community or people, or is
contained in codified knowledge systems passed between generations. It is not limited to any technical field, and may include agricultural, environmental and medicinal
knowledge, and knowledge
9
associated with genetic resources.
What is apparent from both characterizations is that TK is far-ranging and, even more important for the purposes of this paper, TK need
not be old, static, or lacking in a scientific or technological basis. The
knowledge is traditional only in the sense that it is part of the customs
and cultural traditions of the community that has developed and
maintains it.' ° Because the knowledge is often central to a community's cultural value system, the community generally holds and owns
the knowledge collectively, although use of the knowledge may be restricted to certain community members.1 ' The knowledge may also be
communicated orally or recorded in ways different from accepted
Western scientific methodology, terminology or modes of expression.
6. Patents are by no means the only way to protect TK. Arguments have been
made, in fact, that sui generis protection systems or remedies outside of traditional
intellectual property rights, such as contract law and the law of misappropriation, may
be more effective means of protecting TK. The purpose of this article is not to dispute those claims, but simply to discuss the benefits and challenges of looking to national patent systems for TK protection.
7. Convention on Biological Diversity, June 5, 1992, 1760 U.N.T.S. 79, 31 I.L.M.
818, available at http://www.cbd.int/doc/legal/cbd-en.pdf [hereinafter CBD].
8. Id. art. 8(j).
9. WIPO, Intergovernmental Comm. on Intellectual Property & Genetic Res.,
Traditional Knowledge and Folklore, Consultation Paper: Recommendations on the
Recognition of Traditional Knowledge in the Patent System
15, WIPO/GRTKF/IC/
13/7 Annex (Sept. 18, 2008) [hereinafter WIPO, Recognition of Traditional
Knowledge].
10. Daniel Gervais, TraditionalKnowledge and Intellectual Property: A TRIPSCompatible Approach, 2005 MICH. ST. L. REV. 137, 140 (2005); see also WIPO, Recognition of Traditional Knowledge, supra note 9 at 2.
11. Gervais, supra note 10, at 140-141. It should be noted that use of the knowledge may also be extensively practiced.
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On the surface, therefore, TK bears resemblance to the sort of intellectual property protected by patents, but there may be significant differences in the way in which the knowledge is developed, held, or
communicated.
WHY PATENT PROTECTION?

Putting the differences in the above paragraph aside, a recent
WIPO IGC consultation paper reported that "a significant number of
patent applications concern inventions which are in some way related
to traditional knowledge." 12 A community's new and innovative advancements in TK may meet the requirements to qualify as patentable
inventions, for example. In such cases, the holders of the TK need to
ask whether they wish to take advantage of patent protection, whether
it is in their best interests to do so, and assuming positive answers to
both questions, whether they have the resources to file, prosecute, and
enforce patent applications.
More typically, inventions claimed by others may make use of a
community's TK in that the others will derive their inventions from
the TK or base their inventions on it.13 When inventions derived from
TK become the subject of patent applications, the relationship between the inventions and their underlying TK may be key to the inventions' patentability. For example, the TK may constitute prior art
that destroys an invention's novelty or non-obviousness. As prior art,
failure to disclose the TK may result in a violation of the duty in
United States patent law to disclose all known information material to
patentability. 4 The TK may also directly relate to the question of
inventorship and entitlement to apply for a patent since the holders of
the TK-and not the named inventor-may constitute the true inventors or co-inventors of the claimed invention.
It is clear, then, that there are critical links between TK and the
patent system. The question is whether and if so, how, those links can
be exploited to foster protection for TK. This question is not a new
one and has been the subject of considerable scholarship. 15 The answer, which may prove more difficult to achieve than to posit, seems
to lie in the objectives of the patent system itself. While the primary
objective of patent law is affirmative, i.e., to enable the grant of exclusive patent rights for qualifying inventions, a patent system also has an
12. WIPO, Recognition of Traditional Knowledge, supra note 9 at 1.
13. Id.
14. See 37 C.F.R. § 1.56 (2000) (failure to disclose material information may result
in a finding of inequitable conduct and in the consequential unenforceability of the
patent).
15. For an extensive bibliography on TK protection, see Krishna Ravi Srinivas,
TraditionalKnowledge and Intellectual Property Rights: A Note on Issues, Some Solutions and Some Suggestions, 3 AsIAN J. WTO & INT'L HEALTH L. & POL'Y 81,

112-120 (2008).
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important defensive objective, to ensure the denial of rights to inventions that are already known or lack a sufficient level of inventiveness.
In addition, a patent system has a vital informational objective, to
guarantee the disclosure to third parties of all relevant information
concerning the invention as a quid pro quo for the grant of exclusive
rights. Countries wishing to use patents to protect TK would do well
to consider measures that reflect all three objectives. Such a threepronged approach would focus on putting into place legislative or
other mechanisms to provide for (1) defensive protection of TK, (2)
disclosure of TK, with consequent provision for benefit sharing, and/
or (3) affirmative protection of qualified TK through the grant of patent rights.
Defensive protection would ensure that none other than the holders
of TK would be able to acquire intellectual property rights over that
knowledge. a6 Effective measures would include, on the one hand, the
adoption of legislation that recognizes TK as prior art and the creation
of information systems to make TK searchable by patent offices,17
and, on the other, the establishment of strong trade secret measures
that allow the holders of TK to maintain the confidentiality of their
knowledge should they choose to do so.' 8 At the heart of the second
prong-disclosure and benefit sharing-is a community's right to
maintain control over its TK. Inherent in that control are measures
that would require applicants for patents for inventions derived from
or based on TK to disclose in the patent application the geographic
source of that knowledge and to provide assurance that there has been
prior informed consent to make use of the knowledge. The third
prong of affirmative protection would make available information,
mechanisms, and resources to holders of patentable TK to make sure
that those who wished to take advantage of patent protection were
able to assert their rights.
WHY PROTECT TRADITIONAL KNOWLEDGE?

Why should communities that hold TK choose to protect it? There
is of course a moral rationale for protection, i.e., that communities
should have the right to make use of their own TK pursuant to their
own customs and policies, free from misappropriation or misuse by
others. In addition, holders of TK may be motivated by economic,
social, and environmental interests. Professor Graham Dutfield, a
noted scholar on TK and intellectual property protection, has examined several of those interests. 19 With respect to economic mo16. WIPO, Recognition of TraditionalKnowledge, supra note 9 at $ 13.
17. Id.
18. Although trade secret protection for TK is worthy of in-depth discussion, it is
not included in this paper.
19. GRAHAM DUTFIELD, INTELLECTUAL PROPERTY, BIOGENETIC RESOURCES
AND TRADITIONAL KNOWLEDGE 97-100 (2004); see also Council for Trade-Related

HeinOnline -- 15 Tex. Wesleyan L. Rev. 298 2008-2009

20091

USING PATENTS

tivators, Professor Dutfield has found that "[s]ome indigenous and
local communities depend on traditional knowledge for their livelihoods and well-being, as well as to sustainably manage and exploit
their local ecosystems. ' 2° For example, the World Health Organization (WHO) estimates that up to 80% of the world's population relies
on traditional medicine for primary health care, and organizations
such as the Food and Agriculture Organization (FAO), the World
Bank, and the United Nations Environmental Programme (UNEP)
now encourage the use of TK in sustainable rural development programs. Protecting TK could therefore "help local people to maintain
livelihood security and physical well-being while providing opportunities for economic development."'"
Protecting TK may also benefit national economies by giving countries greater control over the commercial use of their knowledge. TKbased products, including plant-based medicines, health products, cosmetics, and non-wood forest products, represent many developing
countries' value added and are a potentially lucrative source of export
revenue, which sound use of TK protection could help realize. Because TK is often an essential element in the development of other
products, such as pharmaceuticals, dietary supplements, personal care,
pesticides, and even industrial enzymes, protecting TK could also give
developing countries an economic edge in doing business with the industries that make those products and thereby promote domestic
growth.2 2
Protecting TK can also provide significant environmental benefits.2 3
Contrary to the common stereotype that subsistence agriculture is environmentally unfriendly, traditional methods of farming and natural
resource management often incorporate a conservation ethic that can
enhance biodiversity. TK protection would not only contribute to the
preservation of the world's plant and animal diversity, it could also
foster the fair and efficient dissemination of environmentally sound
agricultural methods while benefiting the traditional communities that
created them.
Finally, while the patent system has been accused of facilitating biopiracy by tolerating third-party patenting of TK, using the patent sysAspects of Intellectual Property Rights, Note by the Secretariat: The Protection of
TraditionalKnowledge and Folklore 9, IP/C/W/370/Rev.1 (Mar. 9, 2006), availableat
http://www.wto.org/english/tratop-e/trips-e/ipcw370rl.pdf (providing examples of why
international actions should be taken to protect TK), and Thomas Cottier and Marion
Panizzon, Legal Perspectives on Traditional Knowledge: The Case for Intellectual
Property Protection, in INTERNATIONAL PUBLIC GOODS AND TRANSFER OF TECH.
UNDER A GLOBALIZED INTELLECTUAL PROP. REGIME, 565, 578-581 (Jerome
Reichman & Keith Maskus eds., (2005).
20. DUTFIELD, supra note 19, at 97.
21. Id.
22. Id. at 98. Nevertheless, Professor Dutfield points out that "it is important not
to overestimate the economic potential of TK." Id. at 99.
23. Id. at 99.
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tern appropriately to protect TK can serve more to prevent biopiracy
than to permit it. Biopiracy generally refers to the exploitation of
traditional knowledge or genetic resources-typically by multinational companies-without the authorization of the holders of that
knowledge, and/or the patenting of inventions based on traditional
knowledge without the consent of the knowledge holders or payment
of compensation.2 4 Several cases of alleged biopiracy, including patents granted for neem, turmeric, the enola bean, and quinoa, have
aroused controversy and focused attention on how patenting can lead
to unjust results.2 5 Although it is extremely difficult to estimate the
extent to which biopiracy actually takes place in any particular country, protecting TK could provide some assurance against misappropriation by clarifying the duty that third parties owe to the holders of the
knowledge when the knowledge has contributed to an invention that
is the subject of a patent application.
Thus there are convincing reasons for turning to the patent system
to protect TK. The view is far from unanimous, however, that doing
so makes sound policy. Many traditional communities are reluctant to
embrace the patent system. The high cost of prosecuting and enforcing patents may be one cause for caution on the part of TK holders.
Another may be the structure of the patent system itself. At a recent
seminar on intellectual property, biotechnology, traditional knowledge, and social issues co-hosted by L'Institution Sciences Po and McGill University, Professor Tania Bubela expressed the commonly held
view that:
There is a mismatch between the IP rights framework and TK. The
main problem is that IP rights are time limited. Patenting of TK
also requires public disclosure but most TK is based on cultural and
spiritual beliefs that do not always agree with disclosure. It is also
very difficult to know who holds the traditional knowledge. An appropriate balance needs to be struck between national economic interests and the needs of the communities to which TK owes its
existence.... 26
Based on the same reasoning, the majority of "Indigenous Groups in
Attendance" at a 2000 UNCTAD Expert Meeting on Systems and National Experiences for the Protection of TK, Innovations and Prac24. Id. at 52.
25. See, e.g., Kari Moyer-Henry, Patenting Neem and Hoodia: Conflicting Decisions Issues by the Opposition Board of the European Patent Office, 27 BIOTECHNOLOGY L. REP. 1, 4 (2008); Olufunmilayo B. Arewa, TRIPS and TraditionalKnowledge:
Local Communities, Local Knowledge, and Global Intellectual Property Frameworks,
10 MARO. INTELL. PROP. L. REV. 155, 170-76 (2006); and DUTFIELD, supra note 19, at
52-55.
26. Catherine Saez, IP In Biotechnology In Need Of A New Start, Experts Say,
INTELL. PROP. WATCH, Nov. 21, 2008, http://www.ip-watch.org/subscribers/subscribers
_20081121.php. See infra for a brief discussion on TK and the requirement of public
disclosure.
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tices recommended that "[t]he current IPR system is inappropriate for
the recognition and protection of traditional knowledge systems because of the inherent conflicts between these two systems.... 2
If patents are to be used effectively to protect TK, therefore, the

concerns of the holders of TK will have to be addressed and measures
adopted that are compatible with their communities' values, norms,
and objectives. To the extent that some of the concerns may be based
on lack of confidence in, or misconceptions about, the patent system,
clarification and education will be essential to provide TK holders

with both the self-assurance and the wherewithal to make appropriate
use of patents.
THE INTERNATIONAL FRAMEWORK

Another critical ingredient in using patents to protect TK is the international framework within which patent systems in general, and
TK protection in particular, has to operate. There are a number of
international agreements that touch upon the rights of TK holders,2 8
but three have a particular bearing on the relationship between TK
and the patent system: the Convention on Biological Diversity
(CBD);2 9 the Agreement on Trade Related Aspects of Intellectual
Property Rights (TRIPS);3" and the Patent Cooperation Treaty
(PCT).3" This section will attempt to provide an overview of the requirements, restrictions, and opportunities created by the international framework.
The CBD
The CBD provides particular support for the middle prong of TK
protection: disclosure of the origin of inventions derived from TK,
27. U.N. Conference on Trade and Dev. [UNCTAD], Protecting and Promoting
TraditionalKnowledge: Systems, National Experiences and InternationalDimensions,
at 83, Doc. UNCTAD/DITC/TED/10 (2004) (edited by Sophia Twarog & Promila
Kapoor), availableat http://www.unctad.org/en/docs/ditctedl0_en.pdf. The indigenous
groups in attendance included the Indigenous Peoples Biodiversity Network, the Aboriginal and Torres Straits Islander Commission, Las Organizaciones Indigenas de la
Cuenca Amaz6nica, the Inuit Women's Association, the International Indian Treaty
Council, Ilkerin Loita Maasai, and the Maori. Id. at 84.
28. Those agreements include the ILO Convention No. 169 Concerning Indigenous and Tribal Peoples in Independent Countries, the UPOV Convention for the
Protection of New Varieties of Plants; and the FAO's International Treaty on Plant
Genetic Resources for Food and Agriculture.
29. CBD, supra note 7.
30. Agreement on Trade-Related Aspects of Intellectual Property Rights, Including
Trade in Counterfeit Goods: General Agreement on Tariffs and Trade-Multilateral
Trade Negotiations (The Uruguay Round), 33 I.L.M. 81 (December 15, 1993), available at http://www.wto.int/english/docs-e/legal-e/27-trips.pdf [hereinafter TRIPS
Agreement].
31. Patent Cooperation Treaty, June 19, 1970, 28 U.S.T. 7645, 1160 U.N.T.S. 231
(Jan. 24, 1978), available at http://www.wipo.int/pct/en/texts/pdf/pct.pdf [hereinafter
PCr].
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especially when the traditional knowledge relates to the conservation
and sustainable use of biological diversity. The CBD was adopted in
1992 in response to growing concern over the loss of the world's biological diversity. Currently 191 countries are party to the CBD, although the United States is not one of them. 32 The objectives of the
CBD, as stated in Article 1, are "the conservation of biological diversity, the sustainable use of its components and the fair and equitable
sharing of the benefits arising out of the utilization of genetic resources, including by appropriate access to genetic resources and by
appropriate transfer of relevant technologies. ' 33 It is the CBD's goal
of achieving fair and equitable benefit sharing that is the most relevant to the issue of patent protection and TK.
Although the thrust of the CBD is on appropriate access to and
benefit sharing of a country's genetic resources,3 4 the preamble to the
Convention and Article 8(j) refer expressly to the role of TK in the
access and benefit-sharing process. In its preamble, the CBD recognizes "the close and traditional dependence of many indigenous and
local communities embodying traditional lifestyles on biological resources, and the desirability of sharing equitably benefits arising from
the use of traditional knowledge, innovations and practices relevant to
the conservation of biological diversity and the sustainable use of its
components...."5 In aspiring to realize the goal of benefit sharing,
Article 8(j) states:
Each contracting party shall, as far as possible and as appropriate:
(j) Subject to national legislation, respect, preserve and maintain
knowledge, innovations and practices of indigenous and local communities embodying traditional lifestyles relevant for the conservation and sustainable use of biological diversity and promote their
wider application with the approval and involvement of the holders
of such knowledge, innovations and practices and encourage the equitable sharing of the benefits arising 36from the utilization of such
knowledge, innovations and practices.
32. The United States signed the convention on June 4, 1993, but it never ratified
it. The other countries that participated in the deliberations leading to the adoption
of the convention, but that are not party to it are Andorra, the Holy See, Iraq, and
Somalia.
33. CBD, supra note 7, art. 1.
34. For example, Article 15.4 of the CBD requires that access to genetic resources
"shall be on mutually agreed terms... ," and, in accordance with Article 15.5, "subject to the prior informed consent of the Contracting Party providing such resources ......
To ensure fair and equitable benefit sharing, Article 15.7 requires
Contracting Parties to "take legislative, administrative or policy measures ... with the
aim of sharing in a fair and equitable way the results of research and development and
the benefits arising from the commercial and other utilization of genetic resources
with the Contracting Party providing such resources. Such sharing shall be upon mutually agreed terms." CBD, supra note 7, art. 15.
35. Id. at Preamble para. 12.
36. Id. at art. 8(j).
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THE BONN GUIDELINES

The Conference of Parties (COP) of the CBD, the convention's
governing body, has focused considerable attention on effective ways
for member countries-called Contracting Parties in the Convention-to implement Article 80).37 Among the recommended measures, the COP has urged countries to require disclosure in patent
applications of the source of TK. For example, at its sixth meeting in
2002, the COP adopted Decision VI/2438 containing the "Bonn Guidelines on Access to Genetic Resources and Fair and Equitable Sharing
of the Benefits Arising Out of Their Utilization" (Bonn Guidelines) as
well as recommendations concerning the "[r]ole of intellectual property rights in the implementation of access and benefit-sharing arrangements."3 9 The Bonn Guidelines counsel Contracting Parties to
consider measures that would "encourage the disclosure of the country of origin ...of traditional knowledge, innovations and practices of
indigenous and local communities in applications for intellectual propIn implementing mutually agreed terms for benefit
erty rights . "..."40
sharing, the Bonn Guidelines further call on member countries to contemplate "[t]he possibility of joint ownership of intellectual property
rights according to the degree of contribution."'"
The recommendations of Decision VI/24 echo the urgings of the
Bonn Guidelines. While the recommendations do not mandate any
particular action on the part of member countries, they invite:
Parties and Governments to encourage the disclosure of the origin
of relevant traditional knowledge, innovations and practices of indigenous and local communities relevant for the conservation and
sustainable use of biological diversity in applications for intellectual
37. See, e.g., Conference of the Parties to the Convention on Biological Diversity
[CBD], Implementation of Article 8(j) and Related Provisions,Decisions IV/9, UNEP/
CBD/COP/4/10 (May 4-15, 1998), available at http://www.cbd.int/decisions/?m=COP04&id=7132&lg=0 [hereinafter COP 4, Implementation of Article 80)]; CBD COP 5,
Article 8(j) and Related Provisions, Decision V/16, UNEP/CBD/COP/5/23, (May
15-26, 2000), available at http://www.cbd.int/decisions/?m=COP-05&id=7158&lg=0
[hereinafter COP 5, Article 8(j) and Related Provisions]; and Conference of the Parties to the Convention on Biological Diversity [CBD], Article 8(j) and Related Provisions, Decision VII/16, UNEP/CBD/COP/DEC/VII/16 (Feb. 9-20, 2004), available at
http://www.cbd.int/decisions/?m=COP-07&id=7753&lg=0; and CBD, COP 9, Article
8(j) and Related Provisions, Decision IX113, UNEP/CBD/COP/DEC/IX/13 (May
19-30, 2004), available at http://www.cbd.int/decisions/?m=COP-09&id=11656&lg=0
[hereinafter COP 9, Article 8(j) and Related Provisions].
38. Conference of the Parties to the Convention on Biological Diversity [CBD],
Bonn Guidelines on Access to Genetic Resources and Fairand EquitableSharing of the
Benefits Arising Out of Their Utilization, Decision VI/24/A, UNEP/CBD/COP/6/20
(Apr. 7-9, 2002), available at http://www.cbd.int/decisions/?m=cop-06&d=24 [hereinafter Bonn Guidelines].
39. Id. IT 2-3.
40. Id. 16(d)(ii).
41. Id. 43(d).
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property rights, where the subject matter of the application
con42
cerns or makes use of such knowledge in its development.
That the COP has devoted attention to the link between benefit
sharing and intellectual property rights should not be viewed as surprising since the CBD itself makes that link. Article 16.5 of the CBD
recognizes that "patents and other intellectual rights may have an influence on the implementation of this Convention," and directs member countries to "cooperate in this regard subject to national
legislation and international law in order to ensure that such rights are
supportive of and do not run counter to [the Convention's] objectives." 43 Member countries are entrusted, therefore, to exercise patent rights in support of the objectives of the CBD.
RECENT DEVELOPMENTS

Most recently the COP has expanded its focus to elaborate "Considerations for guidelines for documenting traditional knowledge,"
which are directly related to the question of defensive protection, and
it has engaged in preparatory discussions on the Draft Elements of a
Code of Ethical Conduct, which could have an important impact on
TK protection.4 4 At the ninth session of the COP in May 2008, the
countries expressed concern that recording and documenting TK45
posed potential threats to the holders of the knowledge if the exercise
were carried out without the full and effective participation of the
communities concerned. As a result, the COP in Decision IX/13 asserted that the documentation "should primarily benefit indigenous
and local communities and .

.

. their participation in such schemes

should be voluntary and not a prerequisite for the protection of traditional knowledge. ' 46 To meet that objective, the COP urged Parties,
Governments, and international organizations:
[T]o support and assist indigenous and local communities to retain
control and ownership of their traditional knowledge, innovations
and practices including through:

(a) The repatriation of traditional knowledge, innovations and
practices, in databases, as appropriate; and
(b) Supporting capacity-building and the development of necessary infrastructure and resources;
With the aim of ensuring that:
42. Id. 2.
43. CBD, supra note 7, art. 16.5.
44. Conference of the Parties to the Convention on Biological Diversity [CBD],
Article 8(j) and related provisions, C, Decision IX/13, UNEP/CBD/COP/DEC/IX/13
(May 19-30, 2008), available at http://www.ciesin.columbia.edu/repository/entri/docs/
cop/CBD COP009_decl3.pdf [hereinafter Article 8(j) and Related Provisions].
45. See infra pp. 30-32 for a brief discussion on the establishment of TK
databases.
46. CBD COP 9, Decisions IX/13, supra note 44, C.
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(c) Documentation of traditional knowledge, innovations and
practices, is subject to the prior informed consent of indigenous
and local communities; and
(d) Indigenous and local communities can make informed decisions regarding the documentation of their traditional knowledge,
innovations and practices ....

The recommendation will prove particularly relevant in the elaboration of TK databases to provide defensive protection against the inappropriate claiming of TK-based inventions by third parties.
Among the COP's more ambitious charges is the development of a
code of ethical conduct on respect for the cultural and intellectual heritage of indigenous and local communities relevant to the conservation and sustainable use of biological diversity. 48 The code is intended
to be voluntary, and its aim is to promote respect for and the preservation and maintenance of TK.49 The draft text last discussed at the
ninth session of the COP in May 2008 was still tentative and preliminary, reflecting considerable disagreement among the parties over the
scope of the code. It is thus too early to predict whether, and if so
when, a final text will be approved, or what shape such a text might
take. Many provisions of the current draft have several different options for discussion and the code's text is replete with alternative language within square brackets.5 0 Nevertheless, the draft code contains
several worthy statements concerning the contours of acceptable conduct with respect to TK.
A foundational principle of the code, which has apparently found
acceptance, is the preamble's recognition that "respect for traditional
knowledge requires that it is valued equally with and complementary
to Western scientific knowledge, and that this is fundamental in order
to promote full respect for the cultural and intellectual heritage of
indigenous and local communities relevant to the conservation and
sustainable use of biological diversity."" a The code also recognizes
that TK can be collectively or individually owned, and it states that
"those interacting with indigenous and local communities should seek
47. Id. C J 1.
48. Id. G Annex.
49. Id. Annex 1.
50. Even the draft title of the code contains alternative texts. The title is
presented as "DRAFT Elements of a code of ethical CONDUCT TO [promote] [ensure] RESPECT FOR THE CULTURAL AND INTELLECTUAL HERITAGE OF
INDIGENOUS AND LOCAL COMMUNITIES RELEVANT TO THE CONSERVATION AND SUSTAINABLE USE OF BIOLOGICAL DIVERSITY" (emphasis
added). The differing texts concern apparent differences in opinion about the breadth
of the code; for example, whether the code should apply to all uses of traditional
knowledge "related to the conservation and sustainable use of biodiversity," or only
to those uses "occurring on or likely to impact on, sacred sites and on lands and
waters traditionally occupied or used by indigenous and local communities." Id. % 10.
51. Id. 5. In G, Annex section paragraph 12, the code states that "Traditional
knowledge must be respected as a legitimate expression of the culture, traditions, and
of relevant indigenous and local communities."
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to understand the balance of collective and individual rights and
obligations."52
With those statements in mind, one of the focuses of the code is
transparency in relations between TK holders and third parties in addressing intellectual property issues:
Community and individual concerns over, and claims to, intellectual
property relevant to traditional knowledge, innovations and practices related to the conservation and sustainable use of biodiversity
should be acknowledged and addressed in the negotiation with
traditional knowledge holders and/or indigenous and local communities, as appropriate, prior to starting activities/interactions.
[Knowledge holders should be allowed to retain existing rights, including the determination
of intellectual property rights, over their
53
traditional knowledge.]

In a later paragraph that is still especially tentative and unclear, third
parties are called upon to fully disclose and inform indigenous and
local communities "about the nature, scope and purpose of any proposed activities/interactions" they propose to undertake.5 4
One of the areas of greatest disagreement in the draft seems to be
the extent to which approval or prior informed consent should be
sought before TK can be used by others. The current draft presents
three options,5 5 which range from a blanket statement that
"[t]raditional knowledge should only be used with the approval of the
knowledge holders '' 56 to statements filled with lots of qualifiers. For
example, a variation of one option would limit the ethical obligation
for approval or prior informed consent (both of which are presented
within square brackets) to "[any activities/interactions related to biological diversity, conservation and sustainable use occurring on or
likely to impact on [sacred sites and on lands and waters traditionally
occupied or used by] indigenous and local communities and impacting
upon specific groups.... "157
52. Id. 9 13. The paragraph goes on to say, in square brackets, that, "[The right of
indigenous and local communities to protect, collectively or otherwise, their cultural
and intellectual heritage should be respected.]" Agreement has not yet been reached
on this last sentence.
53. Id. 8. The sentence in square brackets has not been agreed to by the COP.
54. Id. 10 ("Indigenous and local communities should be [fully] informed [to the
fullest extent possible] about the nature, scope and purpose of any proposed activities/interactions carried out by others [that may involve the use of their traditional
knowledge, innovations and practices related to the conservation and sustainable use
of biodiversity] [occurring on or likely to impact on, sacred sites and on lands and
waters traditionally occupied or used by indigenous and local communities]. [Subject
to national law,] this information should be provided in a manner that takes into consideration and activity engages with the body of knowledge and cultural practices of
indigenous and local communities.").
55. Id. T 11.
56. Id. Option B.
57. Id. Option A.
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The deliberations concerning the code of ethical conduct point to
strong international acceptance that users of TK should treat TK, and
the holders of the knowledge, with transparency and respect.
Whether such behavior encompasses an international ethical obligation to disclose the source of the TK and obtain the consent or approval of the TK holders is still the subject of disagreement, however.
The absence of a harmonized international perspective adds compelling weight to the argument that countries wishing to establish a TK
protection system may need to act on their own without the benefit of
a firm international framework.
The TRIPS Agreement
While the CBD loosely supports using patents to protect TK, the
TRIPS Agreement imposes constraints on the actions member countries may take. The TRIPS Agreement, which was elaborated during
the 1986-1994 Uruguay Round of multilateral trade negotiations, introduced enforceable intellectual property rules into the multilateral
trading system for the first time. The agreement was signed on April
15, 1994, and its membership is made up of all WTO member
countries.
Although the TRIPS Agreement does not expressly cover patent
protection for TK, it contains several provisions, including Articles 7
and 8, 27, 29, 32, and 62.1, which are especially relevant to the issue of
disclosure of the source of TK in patent applications. In light of the
CBD's access and benefit sharing provisions, a number of studies have
examined the conformity of the CBD's obligations with the TRIPS
Agreement,5 8 but those studies have reached inconsistent results. As
the studies and deliberations continue with little progress toward consensus, it is unlikely that an international approach will emerge soon.
Basic Principles
Articles 7 and 8 state the objectives and underlying principles of the
TRIPS Agreement. Article 7 emphasizes that intellectual property
rights "should contribute to the promotion of technological innovation and to the transfer and dissemination of technology, to the mutual advantage of producers and users of technological knowledge and
in a manner conducive to social and economic welfare, and to a bal58. See, e.g., Nuno Pires de Carvalho, From the Shaman's Hut to the Patent Office:
In Search of a TRIPS-Consistent Requirement to Disclose the Origin of Genetic Resources and PriorInformed Consent, 17 WASH. U. J. L. & POL'Y 111, 112 (2005); N.S.
Gopalakrishnan, TRIPS and Protection of Traditional Knowledge of Genetic Resources: New Challenges to the Patents System, 27 EUR. INTELL. PROP. REV. 11,
11 (2005); Memorandum from Joshua Sarnoff, Assistant Director, Glushko-Samuelson Intellectual Prop. Law Clinic, Am. Univ. Washington Coll. Of Law, to Steven
Price, President/CEO, Pub. Interest Intellectual Prop. Advisors, Inc. (June 23, 2004);
Gervais, supra note 10; and Srinivas, supra note 15.
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ance of rights and obligations. '59 Article 8 states as TRIPS principles
that "[m]embers may... adopt measures necessary to ... promote the
public interest in sectors of vital importance to their socio-economic
and technological development . . . ." and that "[a]ppropriate measures ... may be needed to prevent the abuse of intellectual property
rights by right holders or the resort to practices which ... adversely

affect the international transfer of technology." '6 Since using patents
to protect TK would seem to promote social and economic welfare in
a manner consistent with Articles 7 and 8, it may be assumed that TK
protection furthers the objectives of, and has place within, the TRIPS
Agreement.
Article 27 broadly regulates the scope of patentability under the
agreement. It provides that WTO member countries must make patents available "for any inventions, whether products or processes, in
all fields of technology, provided that they are new, involve an inventive step and are capable of industrial application."61 The article further provides that countries may not discriminate "as to the place of
invention, the field of technology and whether products are imported
or produced locally.",6 2 These statements clarify that member countries are not free to impose additional substantive conditions of patentability on the grant of patents, nor may they single out particular
categories of inventions for arbitrary treatment.63 Countries may
nevertheless impose administrative requirements or additional substantive requirements concerning the entitlement to apply for a patent, for example,6 4 without seemingly violating the Agreement.
Article 27 goes on to permit several exceptions to patentability,
generally covering fields of technology that most countries have long
deemed off limits to patent protection. According to Article 27.3,
countries may exclude:
(a) diagnostic, therapeutic and surgical methods for the treatment
of human or animals;
(b) plants and animals other than micro-organisms, and essentially
biological processes for the production of plants or animals other
than non-biological and microbiological processes. However, Mem59. TRIPS Agreement, supra note 30, art. 7.
60. Id. art. 8.1-.2.
61. Id. art. 27.1.
62. Id.
63. Countries are free, however, to adopt different rules for particular technologies, provided that the differences in the rules can be supported by bona fide reasons.
In holding that "discrimination" is not the same as "differentiation," the WTO dispute resolution panel held in Canada- PatentProtectionfor PharmaceuticalProducts,
WT/DS 114/R,
7.92, (Mar. 17, 2000), available at http://docsonlinewto.org-WT/
DS114/R, that "Article 27 does not prohibit bona fide exceptions to deal with
problems that may exist only in certain product areas."
64. See Sarnoff, supra note 58, 3,
2.1.11-2.3.2, at 37-43 for a compelling argument that disclosure of TK obligations constitute a permissible substantive requirement concerning the entitlement to apply for a patent.
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bers shall provide for the protection of plant varieties either by patents or by an effective sui generis system or by any effective
combination thereof. The provisions of this subparagraph shall be
reviewed four
years after the date of entry into force of the WTO
65
Agreement.
The review of Article 27.3(b) began in 1999,66 and in 2001 the adoption of the Doha Declaration6 7 added an extra focus of analysis. Paragraph 19 of the Doha Declaration instructs the member countries to
examine the relationship between the TRIPS Agreement and the
CBD, looking in particular at the protection of TK.6 a As a result of
the Doha Declaration, the protection of TK and the relationship between the CBD and the TRIPS Agreement have become integral
parts of the WTO discussions.
TRIPS and Disclosure of Origin
Of primary concern in those discussions is the place of a disclosure
obligation within the TRIPS Agreement. Responses vary greatly. On
the one hand, a group of WTO member countries represented by Brazil and India6 9 has proposed an amendment to the TRIPS Agreement
that would make disclosure an international requirement. Under the
proposal, to remain in conformity with the TRIPS Agreement, WTO
member countries would have to require patent applicants to disclose
the country of origin of any TK used in inventions, to show evidence
that they received prior informed consent, and to provide evidence of
fair and equitable benefit sharing.7 0 On the other hand, the United
States and several other countries have argued that contractual and
other non-patent-law-based remedies are more appropriate mechanisms to prevent the misappropriation of TK.71 Until such time as
member countries reach a common understanding with respect to TK
disclosure, countries remain free to devise and implement their own
TRIPS-compliant measures.
Article 29 of the TRIPS Agreement may help countries discern the
contours of TRIPS compliance, especially with respect to TK disclo65. TRIPS Agreement, supra note 30, art. 27.3(a)-(b).
66. WTO, supra note 4.
67. World Trade Organization, Ministerial Declaration of 14 November 2001, WT/
MIN(01)/DEC/1, 41 I.L.M. 746 (2002), available at http://www.wto.org/english/the
wto-e/ministe/min0le/mindecle.htm [hereinafter Doha Declaration]. For a brief
background analysis, see WTO, supra note 4.
68. Doha Declaration, supra note 67. For a brief background analysis, see WTO,
supra note 4.
69. The group includes Bolivia, Colombia, Cuba, Dominican Republic, Ecuador,
Peru, and Thailand, and is supported by the African group and other developing
countries. See Council for Trade-Related Aspects of Intellectual Property Rights,
Note by the Secretariat:The Relationship Between the TRIPS Agreement and the Convention on Biological Diversity, 71 & n.135, IP/C/W/368/Rev.1 (Feb. 8, 2006).
70. Id. 71.
71. See WTO, supra note 4.
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sure. Echoing most national patent legislation, Article 29 requires
"that an applicant for a patent shall disclose the invention in a manner
sufficiently clear and complete for the invention to be carried out by a
person skilled in the art. .. ."72 With respect to inventions derived
from TK, a cogent argument can be made that disclosure of the TK
and the origin thereof is necessary to describe fully the background of
the invention, how the invention came about, and how it is novel over
the prior art.73 Since such a disclosure would seem to fall within the
permissible scope of Article 29, there is little likelihood that it would
be deemed to constitute an additional substantive condition of patentability prohibited by Article 27. 74
Article 62.1 of the TRIPS Agreement, which gives member countries the right to establish reasonable procedures, would seem to support such an interpretation. The article provides that "[m]embers may
require, as a condition of the acquisition or maintenance of [patent]
rights ... compliance with reasonable procedures and formalities...
consistent with the provisions of this Agreement. ' 75 Compelling disclosure and even requiring the submission of supporting evidence,
such as a certificate of origin or benefit-sharing agreement, arguably
fall within the confines of reasonable procedures that do not create an
undue burden on patent applicants in much the same way that the
inventor's oath and other requirements under US law are considered
TRIPS compliant.7 6
What seem somewhat less clear are the consequences that may follow if a TK disclosure requirement is violated. At issue, in particular,
is whether the TRIPS Agreement would permit a country to refuse to
grant or to revoke a patent if an applicant did not comply with the
disclosure requirement, or whether failure to comply would simply
render a patent unenforceable. The answer seems to depend largely
upon how that requirement is categorized. If, as Professor Joshua Sarnoff has argued, a requirement to disclose the source of TK is adopted
expressly as a substantive condition of entitlement to apply for and
own a patent, there is nothing in the TRIPS Agreement to prohibit a

72. TRIPS Agreement, supra note 30, art. 29.
73. See, e.g., DUTFIELD, supra note 19, at 112.
74. For a contrary view, see Carvalho, supra note 58, at 121.
75. TRIPS Agreement, supra note 30, art. 62.1.
76. See 35 U.S.C. § 115 (2006), which provides, "The applicant shall make oath
that he believes himself to be the original and first inventor of the process, machine,
manufacture, or composition of matter, or improvement thereof, for which he solicits
a patent; and shall state of what country he is a citizen." Similarly, 35 U.S.C.
§ 202(c)(1) (2006) requires small business firms or non-profit organizations that receive Federal Government funding to mention in the patent application that the invention was made under Federal financial assistance.
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country from coupling the requirement with reasonable remedies, 77including rejection of the application or revocation of patent rights.
Professor Sarnoff's argument can find support in Article 32 of the
TRIPS Agreement, which provides for the right of judicial review.
Under Article 32, member countries must make available "[a]n opportunity for judicial review of any decision to revoke or forfeit a patent. .. "78 This provision is noteworthy in that it does not limit the
grounds on which a patent may be invalidated; in fact, the TRIPS
negotiators specifically rejected a proposal to limit the grounds for
revocation or forfeiture to the substantive criteria for patentability.7 9
Provided applicants or patentees had recourse to judicial review flowing from their failure to comply with TK disclosure requirements, Article 32 would not be a stumbling block to TRIPS compliance, but
rather would tend to support it.
Even if disclosure of the source of TK were not considered a substantive condition of entitlement to apply for a patent, compliance
with the TRIPS Agreement would still be achievable, provided that
failure to disclosure the TK did not render the invention unpatentable
but rather made the patent unenforceable, especially if an opportunity
to correct the failure were available. Such an approach would treat
disclosure as a simple administrative requirement in compliance with
the TRIPS Agreement.
While conformity of TK protection with the TRIPS Agreement has
given rise to considerable discussion and debate, careful crafting of
TK protection provisions at the national or regional level, especially
concerning disclosure of origin requirements, should allow national or
regional legislation to escape any potential TRIPS pitfall.
The PCT
The PCT, a treaty that was concluded in 1970, entered into force in
1978, and is administered by WIPO, creates a unified procedure to
facilitate the filing of patent applications worldwide. Under the PCT
framework, applicants can acquire patent rights in any number of PCT
member countries 80 by filing a single "international" application instead of having to file separate applications in every country in which
they seek protection. All applications receive a non-binding search of
the prior art by a major patent office and are published by the International Bureau of WIPO, which gives PCT applicants provisional
77. See Sarnoff, supra note 58, 3, IT 2.2.8-2.2.10. Sarnoff cautions, however, that
it would be prudent to give applicants or patentees the opportunity to cure failures to
disclose the source of the TK, even intentional ones, with permanent loss of rights.
78. TRIPS Agreement, supra note 30, art. 32.
79. See Sarnoff, supra note 58, at 42.
80. At the time of drafting this article, the number of PCT member countries was
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rights. The PCT has become today's standard means of obtaining international patent protection.
The PCT process is divided into two phases: a first international
phase, during which the provisions of the treaty and its accompanying
regulations govern the prosecution and processing of applications; and
a national phase, when international applications are converted into
bundles of national applications and national law and practice gener-

ally prevail. The PCT raises issues regarding TK protection in at least
two respects, and while both directly concern the international phase,

they have national phase implications. The first issue concerns the
extent to which countries are free to create rules, in particular relating
to the disclosure of origin of TK, that have an impact on the international phase. The second concerns the extent to which the non-binding prior art search that occurs during the international phase is likely
to identify and properly search inventions based on TK.
National Rulemaking
With respect to national rulemaking, Article 27(1) of the PCT 1l
provides that "[n]o national law shall require compliance with requirements relating to the form or contents of the international application
different from or additional to those which are provided for in this
Treaty and the Regulations. 8'

under the

PCT8 3

2

Rules 4 and 51bis.1 of the Regulations

generally govern the permissible contents of an inter-

81. Article 6(1) of the Patent Law Treaty (PLT) - a treaty aimed at harmonizing
national patent law procedure - contains an analogous provision:
6(1) [Form or Contents of Application] Except where otherwise provided for
by this Treaty, no Contracting Party shall require compliance with any requirement relating to the form or contents of an application different from
or additional to:
(i) the requirements relating to form or contents which are provided for in
respect of international applications under the Patent Cooperation Treaty;
(ii) the requirements relating to form or contents compliance with which,
under the Patent Cooperation Treaty, may be required by the Office of, or
acting for, any State party to that Treaty once the processing or examination
of an international application, as referred to in Article 23 or 40 of the said
Treaty, has started;
(iii) any further requirements prescribed in the Regulations.
Patent Law Treaty, art. 6(1), June 1, 2000, 39 I.L.M. 1049 (2000), available at http://
www.wipo.int/treaties/en/ip/plt/trtdocs-wo038.html#P105_12369.
The PLT entered
into force on April 28, 2005, but, at the time of drafting this article, had only 18 member countries. The United States is a signatory but has not yet ratified the treaty.
Although the PLT is not covered separately in this article, wherever relevant, anything said about the PCT should be considered to apply analogously to the PLT.
82. PCT, supra note 31, art. 27(1).
83. Regulations under the Patent Cooperation Treaty, Rule 4, 51bis.1, June 19,
1970 (as in force from July 1, 2008), availableat http://www.wipo.int/export/sites/www/
pct/en/texts/pdf/pct regs2008.pdf [hereinafter PCT Regulations], Rules 4 and 51bis.1.
With regard to Rule 4, which is quite lengthy, the provisions that are particularly
relevant to the question of the declaration of the source of TK are 4.1(c)(iii), 4.17, and
4.18(a).
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national application. Although the rules permit applicants to include

certain declarations84 in the international application form concerning
which national patent offices may require evidence or documentation,

a declaration concerning the source of TK used in the invention is not

one of the declarations mentioned. 5 To remedy this gap, in May 2003
the Government of Switzerland proposed an amendment to the PCT
Regulations that would explicitly enable national patent laws to re-

quire the declaration of the source of traditional knowledge in inter-

national patent applications. 86 Despite repeated discussion at PCT
meetings, the proposal failed to achieve consensus among the PCT
member countries and has not been adopted.8 7
Nevertheless, the PCT should not be viewed as preventing national
laws from addressing the issue of disclosure and benefit sharing in the
national phase, particularly if the penalty for failure to disclose or

share benefits is linked to the enforceability of patent rights. Countries are free to treat patents granted on the basis of PCT applications

just as they would treat patents granted from national applications.
Nothing in the PCT, therefore, prevents countries from holding patents unenforceable if the patent holders fail to meet a disclosure
obligation.
An argument can also be made that the PCT tacitly permits patent
offices to invalidate national phase applications or revoke the result-

ing patents if they do not disclose the source of TK. Article 27(3) of
the PCT provides that "[w]here the applicant, for the purposes of any
designated State, is not qualified according to the national law of that

State to file a national application because he is not the inventor, the
84. See id. Rule 4.17, which permits declarations that correspond to the matters set
out in Rule 51bis.l(a)(i) to (v), including declarations as to the identity of the inventor, the applicant's entitlement to apply for and be granted a patent, the applicant's
entitlement to claim priority, inventorship, and non-prejudicial disclosures. Rule
4.18(a), PCT Regulations, prohibits national laws from requiring applicants to furnish
more information at the international phase than is required under the regulations.
85. It is worthwhile noting that the rules apply only to the contents of the application form, not to the body (the description of the invention) of the application.
Therefore, applicants would be expected to declare the TK as well as the source
thereof in the description if doing so were essential to meeting the enablement
requirement.
86. See WIPO, PCT Union, Working Group on Reform of the PCT, 4th Session,
May 19-23, 2003, Proposalsby Switzerland Regardingthe Declarationof the Source of
Genetic Resources and Traditional Knowledge in Patent Applications, Doc PCT/R/
WG/4/13 (May 5, 2003), available at http://www.wipo.int/edocs/mdocs/pct/en/pct-r-wg
_4/pct-rwg_4_13.pdf; and WIPO, PCT Union, Working Group on Reform of the
PCT, 6th session, May 3-7, 2004, Additional Comments by Switzerland on its Proposals Regarding the Declaration of the Source of Genetic Resources and Traditional
Knowledge in Patent Applications, Doc. PCT/R/WG/6/11 (Apr. 21, 2004), available at
http://www.wipo.int/edocs/mdocs/pct/en/pct-r.wg__6/pct-r-wg_6_11.pdf.
87. The principal opponents of the proposal were a group of industrialized countries led by the United States that opposed in principle any requirement of disclosure,
and a group of developing countries led by Brazil and India that preferred to see a
broader resolution of the issue within the context of the TRIPS Agreement.
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international application may be rejected by the designated Office." 88
Since disclosure of the source of TK may be critical in determining
whether the named inventor in the international application has legitimate inventorship rights in accordance with national law, it would
make sense to view Article 27(3) as tolerating a disclosure requirement for the purpose of assessing inventorship rights. This type of
approach, which is based on treating disclosure as a substantive condition of entitlement to apply for a patent, 89 would likely meet with opposition from a substantial number of countries, including the United
States. 90
PCT International Search
The second issue-the extent to which the PCT international search
is likely to identify inventions that are derived from and anticipated by
TK-is most closely related to the defensive protection of TK. The
issue is governed largely by PCT Article 15 on The International
Search and Rule 34 of the PCT Regulations on Minimum Documentation. Article 15(1) states that "[e]ach international application shall
be the subject of international search." 9 1 That search is carried out by
one of fifteen designated International Searching Authorities, all of
which are major patent offices. 9 Although the international search is
preliminary and non-binding, countries, especially developing ones,
tend to rely on it for patenting decisions in the national phase, and
applicants look to it as an early predictor of the likelihood that their
patent applications will achieve success.
The objective of the search, according to Article 15(4) is to "discover as much of the relevant prior art as [the searching authority's]
facilities permit," but the authority "shall, in any case, consult the documentation specified in the Regulations." 93 Rule 34 specifies that the
required documentation, referred to as "Minimum Documentation,"
should consist of patents granted by designated countries, published
PCT applications, and "such other published items of non-patent literature as the International Searching Authorities shall agree
88. PCT, supra note 31, art. 27(3).
89. See Sarnoff, supra note 58,
2.4.5-2.4.8.
90. As was mentioned above (supra note 76), the United States Patent Act itself
contains a substantive condition of entitlement to apply for a patent. Section 115 of
the Act, 35 U.S.C. § 115, requires that all applications filed in the United States be
accompanied by an oath or declaration from the claimed inventors that they believe
themselves to be the original and first inventors of their claimed inventions.
91. PCT, supra note 31, art. 15(1).
92. The current International Searching Authorities are the patent offices from
the following countries and organizations: Australia, Austria, Brazil, Canada, China,
European Patent Office, Finland, India, Japan, Korea, Nordic Patent Institute, Russia,
Spain, Sweden, and the United States. U.S. applicants are authorized to use the
United States Patent and Trademark Office, the European Patent Office, the Korean
Intellectual Property Office, and the Australian Patent Office.
93. PCT, supra note 31, art. 15(4).
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upon.... "9 4 The non-patent literature consists primarily of technical
journals and, until 2005, included no literature related to TK. As a
result, even if a claimed invention had been directly derived from TK,
an examiner carrying out an international search would have had virtually no chance of locating prior art relating to that knowledge. Inventions not worthy of patent protection would accordingly receive
"clean" international search reports.
Beginning in 2004, the PCT International Searching Authorities began adding journals of TK to the list of non-patent literature included
in the PCT minimum documentation. 95 Currently the list contains
fourteen journals. 96 While it is too early to determine whether this
exercise has had any impact, 97 it is at least a start. For the PCT minimum documentation to have an impact on the protection of TK, it will
be essential that more TK journals are added to the list and that patent examiners, particularly those who work in relevant technical fields
such as life sciences and environmental technology, receive training
and awareness in TK and TK systems.
The international framework created by the CBD, the TRIPS
Agreement, and the PCT thus provides support for, but also imposes
some limitations on, using patents to protect TK. The three agreements allow the adoption of legislation and other measures that would
permit countries to implement all three prongs of TK protection, but
they also set parameters that may restrict the options countries have.
The following sections will look in greater depth at the characteristics
of the three prongs of TK protection and will highlight a few of the
efforts of countries that have attempted to put protection systems into
place.
DEFENSIVE PROTECTION OF

TK

The purpose of defensive protection is to prevent anyone other than
the holders of TK from acquiring patent rights over their knowledge.
The protection is defensive in that it serves to preserve the TK holders' right to use the TK they created against any third party who may
later seek to patent inventions derived from it. Defensive protection
94. PCT Regulations, supra note 83, Rule 34.1(b)(iii).
95. See, e.g., WIPO, PCT Union, Meeting of International Authorities Under the
Patent Cooperation Treaty (PCT), 10th Sess., Sept. 13-15, 2004, Doc. PCT/MIA/10/11
(Sept. 15, 2004), available at http://www.wipo.int/edocs/mdocs/pct/en/pct-mia 10/pctmia 10_11.pdf.
96. Those journals are: Acta Pharmaceutica;Economic Botany, Journal of the Society of Economic Botany; Fitoterapia;Indian Journalof TraditionalKnowledge; Journal of Chinese Medicine; Journalof Ethnopharmacology;Journal of Natural Products;
Journalof Nutrition; Korean Journal of Traditional Knowledge; Medicinal and Aromatic Plants Abstracts; Pharmaceutical Biology; Phytochemistry; Phytotherapy Research; and Planta Medica.
97. For example, it is not known to what extent, if any, international search examiners are aware of TK and TK systems, and include TK journals in their search
processes.
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entails intentionally disclosing information about the invention,
knowledge, or technology so that the information may count as prior
art and defeat any third-party patent application which claims the TK
and which, if granted, could interfere with the TK holders' right to use
their knowledge.
Defensive protection is thus directly linked to the patent law notion
of prior art, which can loosely be defined as information made available to the public prior to the filing, priority, or invention date of the
patent application. An invention is deemed worthy of patent protection if it is both novel and non-obvious.98 Determining whether an
invention meets those requirements requires a patent examiner to
compare and analyze the claimed invention in relation to the relevant
prior art. An examiner will find in favor of patentability if the invention is neither anticipated by the prior art nor rendered obvious by it.
Because examiners assess patentability in light of the prior art, defensive protection can succeed as a strategy only if TK is effectively included in the prior art, which, in turn, depends upon two critical
factors: that the holders of TK document or disclose information
about the knowledge in such a way as to meet national patent law
requirements to be counted as prior art; and that the information is
available to patent examiners in a readily accessible manner so that it
is likely to be found in a prior art search.99
Challenges to Defensive Protection

A challenge to the protection of TK is that national and regional
requirements vary as to what standards prior art must meet in order to
count in the assessment of patentability. Laws differ, for example, on
whether prior art may include oral disclosures or use of the technology, or whether the disclosure must occur in written form. Even if
oral disclosures or use are included within the prior art, legislation
often requires that the disclosure or use must have occurred locally.
As a result, orally disclosed TK or TK used in another country may
constitute prior art in some countries or regions, but not in others. As
much TK is communicated orally and used locally, this limitation is
problematic.
98. To be patentable, an invention must also fulfill a utility requirement (i.e., it
must be useful or industrially applicable), but that requirement is not directly relevant to the issue of prior art. See, however, the discussion on affirmative patent protection, infra, where the utility requirement is briefly discussed.
99. See WIPO, Intergovernmental Comm. on Intellectual Prop. and Genetic Res.,
Traditional Knowledge & Folklore, PracticalMechanisms for the Defensive Protection
of Traditional Knowledge and Genetic Resources Within the Patent System, J 7, Doc.
WIPO/GRTKF/IC/5/6 (May 14, 2003) [hereinafter WIPO, Practical Mechanisms],
available at http://www.wipo.int/edocs/mdocs/tk/en/wipo-grtkfjic-5/wipo-grtkfic 56.pdf.
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The European Patent Convention 0 0 and the Japan Patent Act,' 0 '
which both define prior art as including oral disclosures and use without geographical limitation, are examples of legislation most favorable
to successful defensive protection. Article 54(2) of the Convention
provides that prior art "shall be held to comprise everything made
available to the public by means of a written or oral description, by
use, or in any other way, before the date of filing of the European
patent application."'" 2 Similarly, under Article 29 of the Japanese act:
(1) An inventor of an invention that is industrially applicable may
be entitled to obtain a patent for the said invention, except for the
following:
(i) inventions that were publicly known in Japan or a foreign country, prior to the filing of the patent application;
(ii) inventions that were publicly worked in Japan or a foreign country, prior to the filing of the patent application; or
(iii) inventions that were described in a distributed publication, or
inventions that were made publicly available through an electric tela foreign country, prior to the filecommunication line in Japan 0or
3
ing of the patent application.'
In contrast, the PCT definition restricts the scope of prior art to
written disclosures only. Rule 33.1 of the PCT Regulations provides
as follows:
[R]elevant prior art shall consist of everything which has been made
available to the public anywhere in the world by means of written
disclosure (including drawings and other illustrations) and which is
capable of being of assistance in determining that the claimed invention is or is not new and that it does or does not involve an
inventive step (i.e., that it is or is not obvious), provided that the
to the public occurred prior to the international
making available
04
filing date.'
Another example of legislation that poses a challenge to defensive
protection for TK is the United States Patent Act. Section 102(a) of
the Act' 015 defines prior art as encompassing oral disclosures or use
100. Conference of the Parties to the Convention on Biological Diversity [CBD],
Bonn Guidelines on Access to Genetic Resources and Fairand Equitable Sharing of the
Benefits Arising Out of Their Utilization, Decision VI/24/A, UNEP/CBD/COP/6/20
(Apr. 7-9, 2002), available at http://www.cbd.int/decisions/?m=cop-06&d=24 [hereinafter Bonn Guidelines].
101. Patent Act, Act No. 121 of 1959 (Japan), available at http://www.cas.go.jp/jp/
seisaku/hourei/data/PA.pdf (unofficial English translation).
102. Bonn Guidelines, supra note 100 (using the term "state of the art" synonymously with prior art).
103. Patent Act No. 121 of 1959 art. 29(1).
104. PCIT Regulations, supra note 83, Rule 33.1(a). Although this definition governs only the non-binding international search carried out during the international
phase of the PC', the results of that search, especially if they are positive, carry persuasive weight in national patent grant procedures in many countries.

105. See Patent Act 35 U.S.C. § 102(a) (2006).
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only if the acts occurred in the United States; written disclosures, however, are included regardless of where they occurred. The section
states, "A person shall be entitled to a patent unless (a) the invention
was known or used by others in this country, or patented or described
in a printed publication in this or a foreign
country, before the inven10 6
tion thereof by the applicant for patent.'
The difficulty that narrow definitions of prior art pose is that they
shift the burden to the holders of TK to ensure that the knowledge is
disclosed in a manner sufficient to be included in the prior art. Meeting this burden is not only onerous and inconsistent with the manner
in which TK is typically held and managed, but at times it may prove
counterproductive to the best interests of TK holders. Defensive protection alone-without the assertion of affirmative patent rights-entails placing in the public domain TK that may otherwise be
undisclosed, secret, or inaccessible and giving access to it to the public.
Such a move could mean that TK holders would forego the possibility
of acquiring patent rights over the disclosed knowledge, or they could
lose whatever trade secret protection they had previously secured. By
making undisclosed information easily accessible, moreover, defensive
protection could contribute to enabling the unauthorized use of the
very TK that the holders wish to protect. 10 7 Communities that embark on strategies of defensive protection therefore need to make certain that the TK they disclose is knowledge they wish to make publicly
available. For that reason, defensive protection against third-party
misappropriation is perhaps most effective in protecting TK that is
already in the public domain.
Keys to Defensive Protection

With that caution in mind, TK holders who choose to make use of
defensive protection also need to ensure that the strategies they employ are effective. The WIPO IGC has drafted several practical
guidelines that should be considered whenever TK-related information is published.' 08 The following summarizes some of those
guidelines.
106. Id. A comparison of the description of what constitutes prior art in the European Patent Convention and the U.S. Patent Act raises another distinction: the date
on which disclosures constitute prior art for the purpose of assessing patentability.
The European Patent Convention - as well as the legislation of all other countries provides that the effective date is the date of filing of the patent application; the U.S.
Patent Act, however, provides that it is the date on which the claimed invention was
reduced to practice. See generally Margo Bagley, Patently Unconstitutional: The Geographical Limitation on Prior Art in a Small World, 87 MINN. L. REV. 679 (2003)
(general critique of 35 U.S.C. § 102).
107. See WIPO, Recognition of TraditionalKnowledge, supra note 9, 1 14, in this
regard.
108. WIPO, PracticalMechanisms, supra note 99, T 24.
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One of the most important is that the disclosure should be publicly
available and contain an unambiguous publication date.'0 9 For prior
art to be considered relevant in the examination of a patent application, the prior art must have been made available to the public (not
simply written down and set aside) before the filing, priority, or invention date of the application. If the date cannot be determined, the
information will be ignored. A clear and unambiguous publication
date is especially important in the case of internet-based prior art disclosures. Because the date of posting of internet-based content is
often unclear, and internet databases and websites can be easily
amended, it is critical that prior art information posted on the internet
remain consistently available and the date of posting of the information (as well as the dates of posting of any subsequent or supplementary information) be readily determinable."' 0
The content of the disclosure is also of prime importance. The publication should ideally contain a complete and comprehensive description of the innovative or technological concept behind the TK."'
Incomplete disclosures leave open the possibility that patent claims on
undisclosed aspects of the TK will be considered valid. The publication should also strive to include descriptions of uses of the TK, both
those that have already been demonstrated and other more speculative ones, and it should aim to describe the technological concept behind the TK in a sufficient enough manner to meet the patent law
requirement of enabling a person skilled in the art to carry out the
invention. Although the content should therefore be as complete as
possible, there is at least one element that it should avoid including.
The disclosure should steer clear of statements about the TK's limitations or about what the TK cannot do, since such statements may result in strengthening the patent applications of inventions that claim
to overcome the TK's shortcomings." 2
TK Databases
As mentioned above, unless the information is available to the public, it cannot constitute prior art. From the perspective of defensive
protection, the requirement of public availability means ensuring that
information about TK can be found easily by both researchers and
patent examiners. One of the most effective ways to achieve the objective of public availability, in addition to publication in TK technical
journals, is by including information about the TK in an accepted TK
database.
109. Id. I 24(b). When TK is being cited as prior art because it was publicly used,
the ability to pinpoint the date upon which the use first occurred is as crucial as being
able to establish a clear publication date.
110. Id. 'I 24(c).
111. Id. 24(d).
112. Id.
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While the number of TK databases worldwide is still limited, a few
stand out as having amassed a considerable collection of reliable data.
Principal among those is the Indian Traditional Knowledge Digital Library (TKDL).1 13 Begun in 2001, the TKDL is a collaborative project
of a number of Indian Government institutes and ministries, 1 4 the
objective of which is to document the body of knowledge that is available in the public domain on the traditional Indian systems of
medicine1 15 and to protect that knowledge from misuse by third parties attempting to obtain patents on non-novel and obvious innovations. The staff of the TKDL consists of traditional medicine experts,
patent examiners, IT experts, scientists, and technical officers, whose
job it is to compile and reference centuries-old TK that has been described in ancient texts in Sanskrit, Urdu, Persian, or other generally
inaccessible languages and passed down by word of mouth. The
TKDL also provides the contemporary names for the medicinal
plants, diseases, and processes described in the texts, establishes the
relationship between that TK and modern concepts, and presents its
data on the Internet in English, French, German, Japanese, and Spanish in patent application format easily understandable by patent examiners. The database currently contains more than 200,000
formulations from the principal traditional Indian medicine systems,
including Aryuveda, Unani, and Siddha.11 6 Typical of patent
databases, it is important to note that the TKDL does not itself constitute the prior art; the TKDL serves as the reference tool that points
examiners to the texts that constitute it. 117 Consequently, the prior art
dates of the references included in the TKDL are generally vastly
older and bear no relation to the dates on which the references were
added to the database.
An additional important contribution of the TKDL was the creation
of the Traditional Knowledge Resource Classification (TKRC), which
is a structured classification system based on the International Patent
113. Traditional Knowledge Digital Library, http://www.tkdl.res.in/tkdl/langdefault/
common/home.asp?GL=Eng (last visited Feb. 22, 2009).
114. The participating government entities are the National Institute of Science
Communication and Information Resources (NISCAIR), the Council of Scientific
and Industrial Research (CISR), the Ministry of Science & Technology, and the Ministry of Health and Family Welfare.
115. The Indian systems of traditional medicine within the scope of the TKDL are
Ayurveda, Siddha, Unani, and Yoga.
116. See Source of Information, http://www.tkdl.res.in/tkdl/langdefault/common/
AboutTKDL.asp (last visited Feb. 27, 2009) (1 lakh = 100,000, so more than 2 lakh
means more than 200,000).
117. For example, ancient Sanskrit texts were used in reexamination to invalidate
United States patent 5,401,504 for "a method of promoting hearing of a wound in a
patient, which consists essentially of administering a wound-healing agent consisting
of an effective amount of turmeric powder to said patient." The texts, which qualified
as written prior art disclosures, demonstrated that the claimed invention (use of turmeric) was well-known TK.
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Classification (IPC) 118 that facilitates the arrangement, dissemination,
and retrieval of the information included in the TKDL. 119 The TKRC
has greatly expanded the system of classifying traditional medicine by
adding about 25,000 subgroups relating to medicinal plants, minerals,
animal resources, and methods of medicinal preparation and administration as compared to the very few subgroups that had been included
in the IPC. The success of the TKRC has also led to a substantial
increase in the IPC's coverage of TK, in particular, to the inclusion of
more than 200 subgroups covering different categories of medicinal
the establishment of linkages between both classificaplants, and to
120
tion systems.
Two additional models of TK databases come from China and focus
on Traditional Chinese Medicine: the China TCM Patent
Database, 121 and the Chinese Medical Literature Analysis and Retrieval System (TCMLARS).1 22 The TCM Patent Database was developed within the State Intellectual Property Office of China initially
to assist patent examiners. It now exists also in English and is fully
accessible to the public. The database includes over 22,000 patent
records dating from 1985 to the present and 40,000 Traditional Chinese Medical formulations. It also possesses a sophisticated classification system and easy-to-use search tools. TCMLARS,12 3 which is
administered by the Academy of Traditional Medicine, is a database
of information contained in more than 800 biomedical journals published in China since 1984, and it currently contains about 68,000
records, which are all extensively indexed. A portion of TCMLARS
exists in English.
The Indian and Chinese databases are models for other countries to
emulate. 124 They call attention to the importance of TK and make it
feasible for patent examiners to discover TK-related prior art. The
addition of a broad range of TK databases would have the dual bene118. For background about the IPC, see http://www.wipo.int/classifications/ipc/en/
(last visited on Feb. 23, 2009).
119. See Traditional Knowledge Resource Classification (TKRC), http://www.tkdl.
res.in/tkdl/LangDefault/Common/TKRC.asp?GL= (last visited on Feb. 23, 2009).
120. See About TKDL, http://www.tkdl.res.in/tkdl/langdefault/common/AboutTKD
L.asp (last visited Feb. 27, 2009).
121. See China TCM Patent Database, http://chmp.cnipr.cn/englishversion/help/
help.html (last visited Feb. 23, 2009).
122. See Traditional Chinese Medical Analysis and Retrieval System (TCMLARS)
English Version, http://www.cintcm.com/e_cintcm/version.htm (last visited Feb. 15,
2009).
123. An excellent description of TCMLARS can be found in Weiyu Fan, The Traditional Chinese Medical Literature Analysis and Retrieval System (TCMLARS) and Its
Application, 35 INT'L J. SPECIAL LIBR. 147 (2001).
124. For a list of other online databases containing TK documentation, see Manuel

Ruiz, CTR.

FOR INT'L ENVTL. LAW, THE INTERNATIONAL DEBATE ON TRADITIONAL
KNOWLEDGE AS PRIOR ART IN THE PATENT SYSTEM: ISSUES AND OPTIONS FOR DEVELOPING COUNTRIES 22-23 (2002), available at http://www.ciel.org/Publications/

PriorArt_ManuelRuiz_Oct02.pdf.
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fit of making it easier for the holders of TK to engage in defensive
protection while increasing the integrity of the patent system by
preventing the grant of invalid patents.
Patent Monitoring

There is yet an additional element to effective defensive protection:
monitoring patent applications and patent grants to take action
against those who inappropriately claim TK. While patent monitoring
is a fairly costly and burdensome task, it would be rendered much
more practicable if patent applicants were required to disclose the
source of any TK from which the claimed invention was derived or
upon which it was based. The following section will discuss
mandatory disclosure of the source of TK and provision for benefit
sharing, which is the middle prong of TK protection.
DISCLOSURE OF THE SOURCE OF

TK

AND BENEFIT SHARING

Requiring the disclosure of the source of TK in patent applications
has multiple benefits. Disclosure calls attention to whether the TK
holders have claims of inventorship or ownership rights in the invention, and it signals the need to include TK within the scope of the
prior art search. It also aids in ensuring that the patent applicant has
obtained the prior informed consent of the TK holders, and it
monitors enforcement of access and benefit-sharing
obligations in
125
conformity with CBD Article 8(j) obligations.
Inventorship

The issue of whether an applicant or inventor is entitled to apply for
a patent or claim inventorship rights is distinct from the question of
whether an invention is patentable. With respect to inventions derived from TK, the question of inventorship and entitlement becomes
particularly relevant when the holder of the TK is not acknowledged
in the patent application. Since the TK holder may be entitled to
claim inventorship or ownership rights in the TK-based invention, determining the TK holders' status may have an important impact on the
validity of the application or any ensuing rights.
It is a firmly established principle that "[t]he inventor shall have the
right to be mentioned as such in the patent' 1 6 even if the inventor has
no rights in the patent itself. According to the secretariat of WIPO:
125. Friends World Comm. For Consultation [FWCC], Quaker U.N. Office, Occasional Paper 16: The Politicsand Practicalitiesof a Disclosure of Origin Obligation, 3
(Jan. 2005) (prepared by Carlos M. Correa).
126. WIPO, Paris Convention for the Prot. of Indus. Prop., art. 4ter Mar. 20, 1883,
as last amended Oct. 2, 1979, 21 U.S.T. 1583, 828 U.N.T.S. 305, available at http://
www.wipo.int/treaties/en/ip/paristrtdocs-wo020.pdf.
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Identifying the inventor or inventors is fundamental as the patent
right is derived, directly or indirectly, from the act of invention. An
applicant who does not have the required relationship with the
actual inventor or inventors (e.g., as the inventor, as the inventor's relevant employer, or otherwise as successor in title) is not entitled to a patent right, even if the patent is otherwise fully valid
on substantive grounds (novel, inventive, and industrially
applicable).
127
Failure to declare an inventor or joint inventor may therefore
prejudice the patent right.
An inventor or patent applicant whose claimed invention is derived
from the TK of others may not have any entitlement to a patent. The
patent law and practice of most countries requires that an invention
be the original work of the person named as the inventor in the patent
application. If that person did not conceive the invention but rather
based it in whole or in part on the conception of another, the patent
application may be rejected or the patent deemed invalid in the absence of naming the other person as the inventor or co-inventor.
In the United States, inventorship is governed generally by Section
102(f) of the Patent Act, 35 U.S.C. § 102(f). The section provides that
a person is not entitled to a patent if "he did not himself invent the
subject matter sought to be patented. ' 12 s In interpreting the provision, courts have held that it is proper to reject patent applications
under Section 102(f) when it can be shown that the applicant derived
the invention from another. 12 9 Applying this principle, which can be
found in most patent laws worldwide, the secretariat of WIPO has
suggested the following scenario:
A patent application claims a combination of known traditional ingredients, with the claim that it has a surprising therapeutic effect.
This surprising effect may have been disclosed by a traditional medical practitioner, who had discovered it during the course their (sic)
own experimentation and adaptation of traditional healing methods. In this case, the traditional healer may be the actual inventor,
and the title to agly for a patent may need to be legally derived
from that person.
127. WIPO, Recognition of Traditional Knowledge, supra note 9, 42.
128. Patent Act, 35 U.S.C. § 102(f) (2006).
129. See, e.g., Kusko, 215 U.S.P.Q. 972, 974 (1981). Historically, improper naming
frequently led to invalidation of granted patents; however, § 256 of the Patent Act, 35
U.S.C. § 256, provides that invalidation is not appropriate if the error can be corrected in accordance with the Patent Act.
130. WIPO, Recognition of TraditionalKnowledge, supra note 9, T 47. The example goes on to raise an issue that will be discussed under the section on affirmative
protection for TK: "Ifthe effect, claimed to be surprising, apparently seems to be
consistent with an established traditional medicine system then it may be necessary to
consider whether it would be obvious to a person skilled in the art, a test which may
include practitioners of this form of traditional medical knowledge." Id.
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Even if the traditional medical practitioner were not entitled to full
inventorship rights under the law of a particular country, it is likely
that the practitioner would be declared a co-inventor. In the United
States, Section 116 of the Patent Act, 35 U.S.C. § 116, sets the standard for joint inventorship by providing that it is not necessary for a
co-inventor to "make a contribution to the subject matter of every
claim of the patent.' 131 Therefore, it would be proper to name a TK
holder as an inventor on a patent application containing 10 claims, for
example, even32if the TK holder contributed to the conception of just
one of them.
The United Kingdom seems to have adopted a similar approach.
At least one case has held that the person who generated the idea for
an invention but did little else had made a significant enough inventive contribution to be treated as a co-inventor. 133 Analogizing to TK,
where an applicant or inventor would not have developed an invention without the knowledge and prompting of the TK holder, the
holder would be entitled to co-inventor status, which might also include ownership rights. Requiring disclosure is therefore a valuable
mechanism to assure that rights of inventorship and ownership go to
those who deserve them.
Approaches to Disclosure
Disclosure is also a direct and effective means of ensuring compliance with the prior informed consent and fair and equitable benefitsharing obligations of Article 8(j) of the CBD. Countries that have
disclosure provisions in place have adopted various approaches.
While some countries or regions have introduced legislation directly
into their patent law, 13 4 others have adopted separate legislative
mechanisms, 35 and still others have combined both. India and the
131. 35 U.S.C. § 116(3).
132. See, e.g., Ethicon, Inc. v. U.S. Surgical Corp., 135 F.3d 1456, 1460 (Fed. Cir.
1998) ("[a] contribution to one claim is enough.").
133. See Re Staeng Ltd's Patents, [1996] R.P.C. 183 (Patent Office) (U.K.); see also
WIPO, Recognition of Traditional Knowledge, supra note 9, 44, (quoting LIONEL,
BENTLEY

& BRAD

SHERMAN, INTELLECTUAL PROPERTY LAW

476 (2001)).

134. See, for example, Law on the Protection of Intellectual Property Rights (2003)
(Egypt), available at http://www.egypo.gov.eg/inner/english/PDFs/law2002e.pdf. Article 13 of the Law provides in part that "[w]here the invention involves biological,
plant or animal product, or traditional medicinal, agricultural, industrial or handicraft
knowledge, cultural or environmental heritage, the inventor should have acquired the
sources in a legitimate manner," and Article 14 states that "[t]he Patent Office may,
as stipulated in the Regulations, require the applicant to make any amendments or
complements which it shall deem necessary to comply with the provisions of Article
13. If the applicant fails to comply within three months of notification, he shall be
considered as having withdrawn his application."
135. See, for example, WIPO, Special/Specific Legislative Measures, Legislative
Texts on the Protection of TraditionalKnowledge, available at http://www.wipo.int/tk/
en/laws/tk.html (last visited April 1, 2009).
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Andean Community are two that have followed a combined and comprehensive approach.
In 2002, the Indian Parliament adopted the Patents (Amendment)
Act (No. 38 of 2002).136 An important objective of the amendments

was to prevent the misappropriation of TK associated with genetic
resources. To accomplish this goal, the act not only makes it obligatory
to disclose the source and geographical origin of any biological material used in an invention,137 it also punishes the failure to do so by
adding two new grounds for opposition or revocation of a patent:
"that the complete specification does not disclose or wrongly mentions the source or geographical origin of biological material used for
the invention;" and "that the invention so far as claimed in any claim
of the complete specification was anticipated having regard to the
knowledge, oral or otherwise, available within any local or indigenous
community in India or elsewhere. ' 138 Furthermore, the Act adds TK
to the list of things that are not considered to be inventions within the
meaning of the Act 1 39 and thereby prohibits the patenting of TK per
se. Nevertheless,
inventions based on TK remain eligible for patent
40
protection.
The Indian Patents Act does not oblige the patent applicant to obtain the prior informed consent of the TK holder or to enter into a
benefit-sharing agreement concerning the use of the TK. However,
an associated act, entitled the Biological Diversity Act, 2002,'141 requires patent applicants for inventions based on genetic materials of
Indian origin to obtain the prior informed consent of the National Biodiversity Authority, and it permits the Authority to impose benefit1 42
sharing fees or royalties on the commercial use of the invention.
Sections 6(1) and (2) of the Act provide in part as follows:
136. Patent Act, Act No. 38 of 2002, available at http://ipindia.nic.in/ipr/patent/
patentg.pdf. For an excellent analysis of the Act's amendments concerning disclosure,
see Gopalakrishnan, supra note 58, at 17.
137. The Patents (Amended) Act of 2002 § 8(a), amending section 10(4)(d) of the
principal act, The Patents Act, No. 39 of 1970 (as amended by The Patents (Amendment) Act, 1999) (requiring the applicant to "disclose the source and geographical
origin of the biological material in the specification, when used in an invention.").
The Patents Act has since been amended by The Patents (Amendment) Act, No. 15 of
2005, India Code (2005); however, these latest changes did not modify the 2002
amendments regarding disclosure.
138. The Patents (Amended) Act of 2002 §§ 18(a), 31(a)(v) (amending §§ 25(1)
and 64(1) of the principal Act).
139. The Patents (Amended) Act of 2002 § 4(e) (amending § 3 of the principal
Act). The amendment provides that "an invention which, in effect, is traditional
knowledge or which is an aggregation or duplication of known properties of traditionally known component or components" is not an invention within the meaning of the
Act. § 4(e).
140. See Gopalakrishnan, supra note 58, at 17.
141. The Biological Diversity Act, No. 18 of 2003; INDIA CODE (2003), available at
http://www.grain.org/brl-files/india-biodiversityact-2002.pdf.
142. Id. cl. 6(1)-(2).
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(1) No person shall apply for any intellectual property right by
whatever name called in or outside India for any invention based on
any research or information on a biological resource obtained from
India without obtaining the previous approval of the National Biodiversity Authority before making such application:
Provided that if a person applies for a patent, permission of the National Biodiversity Authority may be obtained after the acceptance
of the patent but before the sealing of the patent by the patent authority concerned.
(2) The National Biodiversity Authority may, while granting the approval under this section, impose benefit sharing fee or royalty or
both or impose conditions including the sharing of financial
143 benefits
arising out of the commercial utilisation of such rights.
Failure to obtain prior informed consent or to comply with benefit
sharing arrangements is punishable under the Act with imprisonment
or a fine," but violations of the Biological Diversity Act are not actionable under the Patents Act. Therefore, there is no authority
under the Patents Act to oppose or revoke patents on the ground that
the National Biodiversity Authority failed to grant approval,
a gap
145
that has been criticized by at least one commentator.
The National Biodiversity Authority is a government agency established by the 2002 Act to help India realize the objectives of the
CBD. 1 46 The Authority is headed by a chairperson "who shall he an
eminent person having adequate knowledge and experience in the
conservation and sustainable use of biological diversity and in matters
relating to equitable sharing of benefits,"1'47 and by members representing all government ministries with interests in tribal affairs and
science and technology. 148 In addition to the Authority's mandate to
grant prior informed consent and impose benefit sharing arrangements, the Authority has jurisdiction to regulate activities related to
biodiversity and to grant foreigners permission to obtain and use biological and genetic resources. 149 Because the Biological Diversity Act
is distinct from the Patents Act, the Indian Patents Office is not represented on the National Biodiversity Authority.
The Andean Community has also implemented a mandatory disclosure regime. The Andean Community is an economic community
consisting of Bolivia, Colombia, Ecuador, and Peru "that decided voluntarily to join together for the purpose of achieving more rapid, better balanced and more autonomous development through Andean,
143. Id.
144. Id. cl. 55.
145. See Gopalakrishnan, supra note 58, at 18.
146. See National Biodiversity Authority India: About Us, http://www.nbaindia.org/
index.htm (last visited Mar. 28, 2009).
147. Biological Diversity Act, cl. 8(4)(a).
148. Id. cl. 8(4)(b)-(d).
149. Id. cls. 3-4.
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South American and Latin American integration. 1 5 ° Decision 391 of
the Andean Community, which establishes a Common Regime on Access to Genetic Resources, 51 and Decision 486 establishing a Common Intellectual Property Regime 15 2 together provide that patent
applications must contain a copy of the contract or authorization for
access if the claimed invention was obtained or developed from genetic resources or TK originating in one of the member countries.
They further provide that patent rights are not valid if they were obtained or used in violation of the terms of the contract or authorization for access.
An objective of Decision 391 is "to recognize the historic contribution made by the native, Afro-American, and local communities
.. ,153 each of which it defines as "a human group whose social,
cultural and economic conditions distinguish it from other sectors of
the national community, that is governed totally or partially by its own
customs or traditions or by special legislation and that, irrespective of
its legal status, conserves its own social, economic, cultural and political institutions or a part of them."' 5 4 In keeping with its objective, as
well as with the CBD, Article 7 of Decision 391155 directs the member
countries to "recognize and value the rights and the authority of the
native, Afro-American and local communities to decide about their
know-how, innovations and traditional practices associated with genetic resources and their by-products." The Decision therefore establishes a multi-layered access to biological or genetic resources
application and authorization procedure that requires the execution of
an access contract containing fair and equitable benefit sharing provisions. 156 Persons violating the Decision are subject to punishment, including "administrative sanctions, such as fines, preventive or
definitive confiscation, temporary or definitive closing-down of establishments and disqualification of the violator from applying for new
accesses in cases of violation of this regime."' 5 7 In addition, member
countries are directed not to acknowledge, as well as to request or
bring nullification actions against, patents "that were obtained or de150. See Comunidad Andina, About Us, http://www.comunidadandina.org/
INGLES/who.htm (last visited Feb. 15, 2009).
151. Andean Community, Decision 391, Common Regime on Access to Genetic
Resources, Bol.-Colom.-Ecuador-Peru, July 2, 1996, http://www.comunidadandina.
org/INGLES/normativa/d391e.htm [hereinafter Decision 391].
152. Andean Community Decision 486, Common Intellectual Property Regime,
Sept. 14, 2000, http://www.comunidadandina.org/ingles/normativa/D486e.htm [hereinafter Decision 486].
153. Decision 391, supra note 151, para. 5.
154. Id. art. 1.
155. Id. art. 7.
156. Id. tit. V.
157. Id., arts. 46, 47.
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veloped through an access activity that does not comply with the pro'
visions of this Decision." 158
Decision 486, which creates a common intellectual property law for
the Andean Community member countries, reinforces the principles
established in Decision 391. Article 26(i) of the Decision not only
requires that a patent application disclose the source of any TK used
in an invention, it also mandates that the application be accompanied
by evidence of authorization to use the TK:
Applications for patents shall be filed with the competent national
office and shall contain:
if applicable, a copy of the document that certifies the license or
authorization to use the traditional knowledge of indigenous, African American, or local communities in the Member Countries
where the products or processes whose protection is being requested was obtained or developed on the basis of the knowledge
originating in any one of the Member Countries, pursuant to the
provisions of Decision 391. .. .
Moreover, the Decision gives the national patent offices the authority
to declare invalid any patent in the event the applicant failed to submit the requisite documentation:
The competent national authority may, either ex officio or at the
request of a party, and at any time, declare a patent null and void,
where:
when pertinent, the products or processes whose protection is being
requested have been obtained or developed on the basis of traditional knowledge belonging to indigenous, African American, or local communities in the Member Countries, if the applicant has
failed to submit a copy of the document certifying the existence of a
license or authorization for use of that knowledge originating in any
one of the Member Countries .... 160
The Andean Community legislation provides a relatively strong
level of TK protection. Because the Decisions directly link disclosure
and benefit sharing to the patent application process and permit the
invalidation of patents that fall short of the disclosure requirements,
the Andean Community provisions are particularly far reaching. Nevertheless, Decisions 391 and 486 have no effect when misappropriation of TK occurs outside the Andean Community in countries that do
not have similar regimes in place. This weakness is unfortunately inherent in all national TK protection systems.
158. Id., Complementary Provisions, 2d.
159. Decision 486, supra note 152, art. 26(i).
160. Id. art. 75(h).
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AFFIRMATIVE PATENT PROTECTION

The view has been expressed that patent protection is not appropriate for TK. A few of the reasons given are that TK is generally collective, it is developed over time, and TK holders do not often employ
Western scientific method.1 6 1 While those assertions may be true for
certain categories of TK, much of TK, in particular traditional
medicine,1 6 2 contains technical solutions that may meet the requirements for, and benefit from, patentability. This section will look at the
possibilities, limitations, and challenges of patenting TK.
Challenges to Affirmative Protection
One of the asserted challenges concerns the community nature of
TK ownership. If TK is held by the community as a whole, one may
question whether the community, and not an individual, may be the
holder of a patent. Professor Daniel Gervais has contended, correctly
so in the opinion of this author, that "[t]o recognize a community as
owner of a patent is not a particularly difficult conceptual jump...
[and] does not threaten the foundations of intellectual property as it
currently exists."16' 3 Neither TRIPS nor the PCT imposes rules on
ownership, and community ownership is little more than an extension
of joint ownership, which is quite common. Assuming the traditional
community itself is not culturally averse to asserting ownership rights,
that an inventor or inventors can be identified, and that some mechanism exists, including customary law, to transfer the rights from the
inventor or inventors to the community, community ownership is perhaps the least of the challenges that TK patenting faces.
In addition to the patent law requirement of novelty, discussed
above, the requirements of non-obviousness and utility raise particular issues with respect to TK. A patent examiner's determination of
whether or not an invention is obvious generally depends upon how
that invention would be viewed by a "person skilled in the art," in
other words, a person possessing ordinary knowledge and skill in the
technical area of the invention. As Professor Gervais has noted, however, "there is an inherent difficulty stemming from the fact that a
determination of who is 'skilled' and what constitutes the relevant
161. See, e.g., Council for Trade-Related Aspects of Intellectual Property Rights,
Note by the Secretariat: The Protection of Traditional Knowledge and Folklore, 32,
IP/C/W/370/Rev.1 (Mar. 9, 2006).
162. The World Health Organization (WHO) defines traditional medicine as "the
sum total of knowledge, skills and practices based on the theories, beliefs and experiences indigenous to different cultures that are used to maintain health, as well as to
prevent, diagnose, improve or treat physical and mental illnesses." WHO, Fact Sheet
on Traditional Medicine No. 134 (Dec. 2008), http://www.who.int/mediacentre/fact
sheets/fs134/en/index.html.
163. Gervais, supra note 10, at 149. There are theoretically few differences between ownership by a traditional community and ownership by a university or corporate entity.
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'art' may not be culturally neutral terms." '64 If the claimed invention
draws in whole or even in part on TK, logic would dictate that the
person skilled in the art would be a person skilled in the relevant TK
system, for example, a traditional medical practitioner, healer, or shaman. But if the knowledge is confidential to the holders of the TK, or
the patent examiner has no familiarity with it and is unable to assess
the invention fully on that basis, the skills of the TK holders may not
be sufficiently taken into account in examining the patentability of the
invention. 65 To overcome this problem, TK holder patent applicants
may have to assume the burden of describing the invention in terms
more readily understood and appreciated by patent examiners.
A similar challenge exists with respect to the patent requirement of
utility. In most countries, the requirement is gauged by the capacity
to apply the invention industrially or commercially, which is evaluated
by patent examiners on the basis of accepted scientific evidence. Such
evidence, in the minds of most patent examiners, is that with which
they are familiar. In the absence of evidence, the invention is deemed
too speculative for patenting. While TK holders might justifiably prefer to describe their TK innovations in terms familiar to them, for example employing traditional descriptions of chemical formulations
rather than "Western" ones, their patent applications will best overcome the utility hurdle only if they incorporate the sort of scientific
terminology that patent examiners are trained to assess. 1 66 Again
looking at this problem in cultural terms, Professor Gervais has stated,
"In the current patent law environment, the scientific method itself
may seem culturally discriminatory to some holders of traditional medicinal knowledge for example, but there is scant hope of avoiding the
filter of accepted scientific canons to gauge the actual utility of an
invention .... 67

The greatest limitation posed by patenting TK, however, concerns
the term of protection. While the hurdles created by the requirements
164. Id. at 154.

165. Id. Professor Gervais suggests providing patent examiners with training in TK
systems "to build cross-cultural bridges," in the same manner as patent offices have
done with instructing examiners on new areas of technology. Id.; WIPO, Recognition
of Traditional Knowledge, supra note 9, 40. The International Bureau of WIPO
recently posed the following question to member countries of the IGC: "If an element of TK . . .is considered available to or accessible by the public outside the

original community that holds the TK, but skills to interpret or practice the art of TK
are limited to the community only, how would the person skilled in the art be assessed
for the determination of inventive step?" See id. for a selection of answers from
China, EPO, Azerbaijan, Australia, Finland, and Trinidad and Tobago.
166. See U.N. Env't Programme [UNEP], WIPO, WIPO-UNEP Study on the Role
of Intellectual Property Rights in the Sharing of Benefits Arising From the Use of Biological Resources and Traditional Knowledge, 23 (2004) (prepared by Anil Gupta)

available at http://www.wipo.int/tk/en/publications/769e-unep-tk.pdf [hereinafter
WIPO & UNEP, Study on the Role of Intellectual Property Rights] (analyzing the
difference between TK and modern science).
167. Gervais, supra note 10, at 153.
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of novelty, non-obviousness and utility can be overcome with relative
ease, the term of patent protection cannot. It is a bedrock principle of
patent law that protection does not last forever; in most cases, it expires 20 years from the filing date of the application, following which
the invention enters the public domain. Moreover, since most patent
applications are published at about eighteen months following the filing of the application, the ability to maintain the confidentiality of TK
vastly diminishes and may vanish entirely early in the application process. As with all inventions, therefore, the decision to seek patent
protection for TK needs to be based on a careful weighing of the benefits the TK holder will derive from the grant of exclusive rights for a
limited period of time balanced against the potential drawbacks of
permanently divulging the TK.16 8
Advantages of Affirmative Protection
Despite the above-mentioned limitations and challenges, patents
have a place in a TK protection system. A prime example is the use of
patents to protect Traditional Chinese Medicine. The practice of
Traditional Chinese Medicine dates back to the beginning of Chinese
history. At its most basic, it is "a systematic practice of distinguishing
among various illness-causing imbalances of qi. [It] achieves health by
restoring a patient's internal yin-yang equilibrium via herbal remedies
'
Traditional Chinese Medicine is of
and physical manipulation."169
enormous importance not only to the Chinese-and the world'shealthcare systems, but also to the Chinese economy. 170 It is no surprise, therefore, that the Chinese Government has made it a policy to
encourage the patenting of innovative Traditional Chinese Medicinal

products.
Although most developing countries tend to find disfavor with the
TRIPS Agreement, the Agreement has proven to be a boon to the
protection of Traditional Chinese Medicine. Prior to the adoption of
Article 27.1 of the TRIPS Agreement, which required China to make
patents available "for any inventions, whether products or processes,
in all fields of technology . . . " the Chinese Patent Law 171 did not
168. Professor Anil Gupta has maintained, for example, that while the basic "recipes" for traditional Indian health systems, such as Ayurvedic, Unani, or Sidhdha, are
not appropriate for patenting, "modifications of these recipes should be permissible
for patenting" under certain circumstances. WIPO & UNEP, Study on the Role of
Intellectual Property Rights, supra note 166, at 161.
169. Benjamin Liu, Comment, Past CulturalAchievement as a Future Technological
Resource: Contradictionsand Opportunities in the Intellectual Property Protection of
Chinese Medicine in China, 21 UCLA PAC. BASIN L. J. 75 at 78 (2003).
170. According to the WHO Traditional Medicine Fact Sheet, supra note 162, "[i]n
some Asian and African countries, 80% of the population depend on traditional
medicine for primary health care," and "[h]erbal medicines are the most lucrative
form of traditional medicine, generating billions of dollars in revenue."
171. Patent Law of the People's Republic of China (adopted at the 4th Meeting of
the Standing Committee of the Sixth National People's Congress on Mar. 12, 1984,
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protect Traditional Chinese Medicine. Since the Law's amendment,
there has been a significant uptake in patent activity, particularly related to Traditional Chinese Medicine-based pharmaceuticals, and
many supporters of Traditional Chinese Medicine believe that this activity has served to incentivize investment in Traditional Chinese
Medicine, increase the Traditional Chinese Medicine knowledge base,
and transform Traditional Chinese Medicine into a major global export asset. 172 Since 1992, when the Patent Law was amended, applicants have filed patent applications with the State Intellectual
Property Office of China (SIPO) at a rate of 1,400 cases a year, 1 73 but
they have not limited their activity to China alone; they have also filed
applications in countries such as Germany, Japan, the United Kingdom, and the United States. Moreover, patent holders have begun to
enforce the rights they have been granted. For example, in February
2007, China Business News reported that a Chinese patentee Traditional Chinese Medicine manufacturer won the first Traditional Chinese Medicine infringement case against another Chinese company.
The patentee was awarded an injunction prohibiting the infringing
174
company from selling the infringing products as well as damages.
The promotion of Traditional Chinese Medicine has led to the establishment of organizations such as the Shanghai Innovative Research Center of Traditional Chinese Medicine (SIRC), 7 5 which in
turn has further encouraged patent protection for TK. Founded in
2000 with support from the Chinese Ministry of Science and Technology and the Shanghai Municipal Government, SIRC seeks to modernize Traditional Chinese Medicine and innovate drug discovery "by
integrating modern life science, chemistry, and information technol76 -just the right formula to
ogy with [Traditional Chinese Medicine]"1
1 77
potential.
patenting
maximize
Although the patent system may not be suited to all types of TK,
using patents to protect Traditional Chinese Medicine seems to have
achieved some success in encouraging new innovation and invention.
amended on Aug. 25, 2000), available at http://www.sipo.gov.cn/sipo-English/laws/
lawsregulations/200203/t20020327_33872.htm.
172. Liu, supra note 169, at 81-82.
173. Murray Lee Eiland, Patenting TraditionalMedicine, 89 J. PAT. & TRADEMARK
OFF. Soc'y 45, 78 (2007).
174. China Business News, Patent Protection for Traditional Chinese Medicine, a
Prominent Problem (Feb. 6, 2007), http://english.ipr.gov.cn/ipr/en/info/print.jsp?ano=53126&col no=928&dir=200702.
175. See Shanghai Innovative Research Center of Traditional Chinese Medicine,
Abount SIRC/TCM, http://www.sirc-tcm.sh.cn/english/index.html (last visited Feb. 12,
2009).
176. Id.
177. According to the WIPO PATENTSCOPE Search Service website, SIRC has
filed at least two international applications for TK-based inventions. See WIPO,
Search International Patent Applications, http://www.wipo.int/pctdb/en/index.jsp (last
visited Feb. 12, 2009).
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Communities working to advance other areas of innovative TK may
do well to follow China's example.
CONCLUSION

TK is often rich, innovative, and complex, and it deserves protection. Using patents to secure TK protection can serve to prevent misappropriation and misuse, enforce prior informed consent and benefit
sharing mechanisms, and permit TK holders to enjoy the benefits of
exclusive patent rights. Until such time as a meaningful international
protection system can be devised that fully respects the needs of TK
holders, national and regional measures to protect TK need to be
adopted. As more countries embrace national or regional TK protection systems, international norms are certain to emerge that will ultimately make international protection a reality.
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